Last reviewed · How we verify

NCT04138472

Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy

Status unknown NA Last updated 7 February 2020
What this trial tests

NA trial testing dexmedetomidine in Laparoscopic Cholecystectomy in 30 participants. Status unknown.

Timeline
30 October 2019
Primary endpoint
29 February 2020
29 February 2020

Quick facts

Lead sponsorSana Urooj
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment30
Start date30 October 2019
Primary completion29 February 2020
Estimated completion29 February 2020
Sites2 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Sana Urooj

Who can join

Adults 20 to 65, any sex, with Laparoscopic Cholecystectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Laparoscopic Cholecystectomy

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04138472.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing